Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MDNAF, Q2 2026
No superinvestor reported holding MDNAF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Medicenna Therapeutics Corp. insiders from Form 4, newest first.
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Medicenna Therapeutics Corp. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding MDNAF in 13F filings for Q2 2026.